Hosted on MSN2d
10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses ExpectationsBiotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results , but sales fell by 10.3% year on year to $165 million.
The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
The strategy is backed with $175.1 million CAD in federal funding to be dispensed over the next seven years through ...
Humanity Protocol is partnering with genomics company Prenetics, to collaborate on blockchain-based identity verification and ...
The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...
CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M ...
Canada's researchers, businesses and institutions are at the forefront of the genomics revolution, unlocking the potential of this transformative science to drive innovation across industries, address ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results